The IDIBAPS Functional Genomics platform incorporates a new automated cell counter
The new Cellometer™ Ascend™ (Revvity) device is a counter that is characterised, among other features, by an automated analysis that provides informa1
The new Cellometer™ Ascend™ (Revvity) device is a counter that is characterised, among other features, by an automated analysis that provides informa1
Hepatic stellate cells are responsible for producing fibrosis in the liver. Under normal conditions, these cells remain dormant, but when liver tissu1
IDIBAPS has published its Action Plan to implement the principles of the Coalition for Advancing Research Assessment (CoARA), thereby upholding its c1
Update (May 7, 2025): Please note that all spots for the upcoming edition of the camp have been fully booked for all weeks.
A study led by the Clínic-IDIBAPS, Universidad de Santiago de Compostela and UCLouvain (Brussels), published in Nature Metabolism, has shown that the1
Funded by the AECC, the third call for BITRECS offers three postdoctoral fellowships for clinician-scientists seeking to boost their research career1
A study led by María Daca-Álvarez and coordinated by Francesc Balaguer, both from the Gastrointestinal and Pancreatic Oncology group at IDIBAPS, has1
A study led by professionals from IDIBAPS-Hospital Clínic Barcelona in partnership with Hospital Sant Joan de Déu reveals that girls and adolescents1
The Scientific Foundation of the Spanish Association Against Cancer has created its own research centre accreditation system to ‘promote excellence i1